510(k) Report

510(k) · Cleared

Cleared

Nelli (Version 7.11)

K251506510(k) TraditionalCleared Nov 21, 2025189-day reviewClass II21 CFR 882.1580

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neuro Event Labs OY · POS Physiological Signal Based Seizure Monitoring System

Cleared on Nov 21, 2025 as substantially equivalent to K181861 (Empatica S.r.l., 2018) after a 189-day review. Its family tree reaches back 3 generations to 2017.

Decided
Nov 21, 2025
Review
189 days
Class
Class II
Product code
POS
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to DEN140033 (2017). No later device cites it as a predicate yet.

  1. Root · 3 generations backDEN140033 CompanionLgch, Inc. · 2017
  2. 2 generations backK172935 EmbraceEmpatica S.r.l. · 2018
  3. 1 generation backK181861 EmbraceEmpatica S.r.l. · 2018 · Recalled
  4. This deviceK251506 Nelli (Version 7.11)Neuro Event Labs OY · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN140033CompanionLgch, Inc.2017—
−2K172935EmbraceEmpatica S.r.l.2018—
−1K181861EmbraceEmpatica S.r.l.20181
0 (this device)K251506Nelli (Version 7.11)Neuro Event Labs OY2025—
FIG. 1 — Lineage of K251506, 2017–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in POS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new POS device

  1. #1 K232915 EpiMonitorscore 19.6 · 39 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181861Embrace
Summary page 5
…Trade Name:​ Embrace Manufacturer:​ Empatica S.R.L. 510(k) Number:​ K181861 Device Description Summary Nelli is a seizure detection and monitoring system based upon the analysis of audio/video recording…
Empatica S.r.l.20181

Also cleared against K181861: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 11 months on median.
  • 1 of the 3 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K181861.

How does its category compare?

All POS devices

POS Physiological Signal Based Seizure Monitoring System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · POS

4in 2025

2017: 12018: 22019: 12021: 12024: 12025: 4
2007high 4 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · POS

154in 2025

2025: 154 days median
2007high 154 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · POS

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · POS

1in 2025

2021: 12024: 12025: 1
2007high 1 (2021) · low 0 (2007)2025

MAUDE reports naming product code POS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20182—00
20191—00
20200—00
20211—01
20220—00
20230—10
20241—01
2025415401
20260—0—

What is it indicated for?

Nelli is indicated for use as an adjunct to seizure monitoring of patients aged 18 years and above in healthcare facilities during periods of rest. The device utilizes automated analysis of audio and video (media) to identify epileptic and non-epileptic seizure events with a positive motor component. The system provides prioritization of identified major seizures and other motor events for review and media playback by a qualified healthcare professional.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251506: Nelli (Version 7.11).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K251506

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026